Authored by: Jonathan Pepe
In today’s rapidly evolving healthcare landscape, innovative partnerships are crucial to overcoming key brand challenges and driving measurable impact. While pharma companies excel in drug discovery and commercialization, the rapid growth of the digital health ecosystem offers new opportunities.
However, the landscape is complex and challenging to navigate, and success requires today’s marketer to look beyond the tried-and-true and to explore impact-focused solutions that will help them win, grow, and keep their best customers via a detailed blueprint for maximizing business results.
In this exclusive white paper, Jonathan Pepe details a four-step approach to evaluate and activate opportunities to apply emerging data sets and innovative technology solutions to drive the identification and engagement of core patient and HCP audiences.
Ensuring deep integration with a brand’s strategy, providing a clear rationale for investment, and creating a foundation for scalable execution that delivers optimal results, the approach leverages audience insights, data-driven individual identification, and connected intelligent platforms to shape unique partnerships that drive higher engagement and better return on investment than traditional paid media channels.
In pharma, risk is a constant, but that doesn’t mean that as a pharma marketer you need to accept it—especially when you have a proven way to mitigate it via a focused approach to delivering impact. The rigor of the approach not only reduces risk, but it also provides a bulletproof rationale for the decisions that underlie your marketing plan and increases confidence that it will work.
Harness the collective expertise of our biotech experts to maximize the value of your asset across every step of your journey to commercialization.
Read moreMany pharma employees reported that if these challenges are addressed, a congress is far more likely to be successful.
Read morePresident Biden’s 2023 Executive Order captures the need to take robust action to tackle some of the risks associated with AI technology
Read more